Showing 3,881 - 3,900 results of 8,597 for search 'effective dysfunction', query time: 0.15s Refine Results
  1. 3881

    A Severe Alzheimer’s Disease Patient Improved by Intravenous Mesenchymal Stem Cell Transplant by Takahiro Honda Pazili

    Published 2024-01-01
    “…After the treatment, smile loss, eye movement dysfunction, and neck immobility were improved. This is the first case report that showed the therapeutic effects of MSCs on terminal symptoms of AD.…”
    Get full text
    Article
  2. 3882

    Olfactory Capacity and Obesity: A Narrative Review of the Literature by Samuel Durán-Agüero, Ana María Obregón-Rivas

    Published 2025-03-01
    “…Additionally, those with olfactory dysfunction may compensate by seeking saltier or sweeter foods, increasing the risk of obesity. …”
    Get full text
    Article
  3. 3883

    Perspectives on the Use of Stem Cells for Autism Treatment by Dario Siniscalco, James Jeffrey Bradstreet, Nataliia Sych, Nicola Antonucci

    Published 2013-01-01
    “…With the prevalence rates for ASDs rapidly increasing, the need for effective therapies for autism is a priority for biomedical research. …”
    Get full text
    Article
  4. 3884

    Tauopathy and cognitive impairment in experimental diabetes mellitus by Mariia V. Matveeva, Yulia G. SamoiIova, Natalia G. Zhukova, Oksana A. Oleynik, Maria A. Rotkank

    Published 2017-08-01
    “…Mechanisms of cognitive dysfunction in patients with DM remain highly unclear, thus complicating the search for effective strategies for the prevention and treatment of dementia. …”
    Get full text
    Article
  5. 3885

    Control of Dendritic Spine Morphological and Functional Plasticity by Small GTPases by Kevin M. Woolfrey, Deepak P. Srivastava

    Published 2016-01-01
    “…Elucidating this signalling process is critical for furthering our understanding of the basic mechanisms by which information is encoded in neural circuits but may also provide insight into novel targets for the development of effective therapies to treat cognitive dysfunction seen in a range of neurological disorders.…”
    Get full text
    Article
  6. 3886

    USE OF ROSUVASTATIN AS A GEROPROTECTOR IN PEOPLE ENGAGED IN NATURAL GAS PRODUCING by A. T. Abdrashitova, T. N. Panova, I. A. Belolapenko, M. V. Frenkel

    Published 2016-01-01
    “…Absence of effective geropreventive means creates the need for pathogenetic way for aging process deceleration. …”
    Get full text
    Article
  7. 3887

    SUCCESSFUL ENDOVASCULAR TREATMENT FOR LCA TRUNK TRIFURCATION LESION by A. S. Nekrasov, A. A. Grechishkin, S. V. Mayngart

    Published 2019-02-01
    “…The atherosclerotic lesion of LCA trunk causes an ischemia in the sufficient area of the myocardium that often results in LV dysfunction, heart failure, and arrhythmia. The risk of death in cases with this pathology reaches 50% at drug treatment. …”
    Get full text
    Article
  8. 3888

    Advancements in State-of-the-Art Ankle Rehabilitation Robotic Devices: A Review of Design, Actuation and Control Strategies by Asna Kalsoom, Muhammad Faizan Shah, Muhammad Umer Farooq

    Published 2025-05-01
    “…Neurological disorders like stroke are one of the main causes of motor dysfunction and gait function disabilities in humans. …”
    Get full text
    Article
  9. 3889

    A Comprehensive Review on Oculomotor Nerve Palsy: Diagnosis and Management Strategies by Yasir Adil Shakor, Raheleh Moravvej, Ali Majdi, Razieh Bahreini

    Published 2025-04-01
    “…The present study comprehensively reviews the common etiologies of oculomotor nerve palsy and the corresponding clinical manifestations and treatment methods to help practitioners with the prompt and accurate clinical diagnosis of the causes and effective management plan. …”
    Get full text
    Article
  10. 3890

    Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities by Noemí Rueda, Jesús Flórez, Carmen Martínez-Cué

    Published 2012-01-01
    “…In conclusion, the use of mouse models is enormously effective in the study of the neurobiological substrates of mental disabilities in DS and in the testing of therapies that rescue these alterations. …”
    Get full text
    Article
  11. 3891

    Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents by Ahmed K. Saleh, Thanaa A. El-Masry, Aya H. El-Kadem, Nada A. Ashour, Nageh A. El-Mahdy

    Published 2025-03-01
    “…To improve patient outcomes, further research is crucial to identify effective therapeutic interventions.…”
    Get full text
    Article
  12. 3892

    Early Treatment of Acute Complex Regional Pain Syndrome after Fracture or Injury with Prednisone: Why Is There a Failure to Treat? A Case Series by Paul Winston

    Published 2016-01-01
    “…Corticosteroids can be an effective treatment option for CRPS after fracture.…”
    Get full text
    Article
  13. 3893

    Toll-like Receptors in Immuno-Metabolic Regulation of Emotion and Memory by Carla Crespo-Quiles, Teresa Femenía

    Published 2025-06-01
    “…We also explore emerging molecular targets with the potential to guide the development of more effective therapeutic interventions.…”
    Get full text
    Article
  14. 3894

    Frontiers in Nondrug Treatment of Sarcopenia: A Review of Pathological Mechanisms and the Latest Treatment Strategies by Qi‐Fei Kuang, Yu‐Qing Ni, You‐Shuo Liu

    Published 2025-06-01
    “…ABSTRACT Sarcopenia refers to the progressive decline and wasting of skeletal muscle function, typically linked to aging or as a secondary effect of various conditions, including systemic inflammation, oxidative stress, and mitochondrial dysfunction. …”
    Get full text
    Article
  15. 3895

    Transplant Glomerulopathy: The Interaction of HLA Antibodies and Endothelium by William Hanf, Claudine S. Bonder, P. Toby H. Coates

    Published 2014-01-01
    “…Transplant glomerulopathy (TG) is a major cause of chronic graft dysfunction without effective therapy. Although the histological definition of TG is well characterized, the pathophysiological pathways leading to TG development are still poorly understood. …”
    Get full text
    Article
  16. 3896

    SLEEP DISORDERS IN NEUROLOGICAL PRACTICE: A ROLE OF MELATONIN IN THERAPY FOR PRIMARY SLEEP AND AWAKENING DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE by N. V. Fedorova, A. V. Nikitina, Ye. N. Gubanova

    Published 2014-07-01
    “…Melaxen has a minimum of side effects and is well tolerated by patients from different age groups.…”
    Get full text
    Article
  17. 3897

    Acupuncture Therapy in the Management of Orofacial Pain and Headaches: A Systematic Review and Meta-Analysis by Ananya Neralla, Silpiranjan Mishra, Sangamesh Ningappa Chinnannavar, S. Bhuvaneshwari, Atul A. Bajoria, Dhirendra K. Singh

    Published 2024-12-01
    “…Background: The patient’s quality of life may be impacted by pain and dysfunction ranging from moderate discomfort to severe agony. …”
    Get full text
    Article
  18. 3898
  19. 3899

    Chinese Experts′ Consensus on the Management of Hypothalamic Obesity Secondary to Sellar Lesions by Hypothalamic and Pituitary Disease Group of China Alliance for Rare Diseases

    Published 2024-10-01
    “…The treatment of the disease is a great challenge to the physicians. To promote effective management for hypothalamic obesity secondary to sellar lesions, our team developed this consensus based on the latest research and clinical experiences in China. …”
    Get full text
    Article
  20. 3900

    PYRITINOL USAGE IN PEDIATRIC NEUROLOGY by N. N. Zavadenko, Yu. E. Nesterovskii, E. V. Kozlova

    Published 2013-07-01
    “…Significant nootropic effect of pyritinol, including neurometabolic, neuroprotective, neurodynamic and other mechanisms, in association with safety and rare side effects of this drug determines its wide usage in pediatric neurology.…”
    Get full text
    Article